Document is current
Any future updates will be listed below
-
Authors
Buch, Maya H. http://orcid.org/0000-0002-8962-5642
Mallat, Ziad http://orcid.org/0000-0003-0443-7878
Dweck, Marc R.
Tarkin, Jason M. http://orcid.org/0000-0002-9132-120X
O’Regan, Declan P. http://orcid.org/0000-0002-0691-0270
Ferreira, Vanessa
Youngstein, Taryn
Plein, Sven
- License Information
-
More Information
Article History
Accepted: 22 July 2024
First Online: 2 September 2024
Competing interests
: M.H.B. has received grant/research support paid to the University of Manchester from Gilead and has acted as an adviser or speaker with funds paid to the University of Manchester for AbbVie, Alfasigma, Boehringer Ingelheim, Galapagos, Gilead Sciences and Pfizer, Inc. M.R.D. has received speaker fees from Pfizer, Radcliffe Cardiology, Bristol Myers Squibb, Edwards and Novartis, and has received consultancy fees from Novartis, Jupiter Bioventures, Beren and Silence Therapeutics.
